background
infecti
respiratori
diseas
transmit
noninfect
subject
infect
person
expel
pathogen
microorgan
surround
environ
cough
sneez
airway
mucu
layer
interact
highspe
airflow
droplet
expel
aerosol
concentr
size
distribut
may
play
import
role
diseas
transmiss
goal
reduc
aerosoliz
respiratori
secret
interf
minim
normal
mucu
clearanc
use
agent
capabl
increas
crosslink
mucin
glycoprotein
network
method
expos
mucu
simul
ms
airflow
simul
cough
machin
scm
ms
rang
nonvisc
nonelast
substanc
water
ms
vari
degre
viscos
elast
mucociliari
clearanc
ms
assess
frog
palat
elast
filancemet
aerosol
pattern
bullsey
target
sampl
load
weigh
cough
maneuv
test
two
mucomodul
sodium
tetrabor
xl
b
calcium
chlorid
xl
c
result
mucociliari
transport
close
normal
speed
viscoelast
sampl
compar
nonelast
nonvisc
viscousonli
sampl
spinnabl
rang
cm
amount
ms
expel
scm
increas
ad
xl
b
concurr
particl
invers
reduc
almost
disappear
aerosol
pattern
aerosoliz
ms
modifi
increas
cohes
therebi
reduc
number
particl
expel
scm
interf
minim
clearanc
frog
palat
unexpect
find
ms
crosslink
increas
expector
infecti
respiratori
diseas
prime
caus
morbid
mortal
health
system
util
worldwid
greater
impact
develop
least
develop
countri
respiratori
infect
includ
tuberculosi
tb
caus
million
death
mortal
rate
part
burden
sinc
individu
infect
often
unabl
work
becom
trap
viciou
cycl
ill
health
poverti
virus
bacteria
caus
infecti
respiratori
diseas
pathogen
travel
countri
countri
differ
contin
matter
hour
exemplifi
recent
outbreak
sar
children
elderli
defect
immun
system
underli
chronic
diseas
highest
risk
affect
airborn
infecti
diseas
health
care
provid
risk
acquir
transmiss
respiratori
diseas
provid
care
work
contamin
environ
sar
outbreak
valid
concern
advanc
fear
flu
pandem
sar
also
confirm
infecti
diseas
caus
great
disrupt
sector
econom
educ
recreat
famili
bring
health
care
system
near
collaps
sever
strategi
devic
design
protect
variou
sector
societi
whether
peacetim
conflict
differ
individu
protect
barrier
surgic
mask
face
shield
respiratori
protect
equip
use
howev
yield
much
lower
protect
theori
might
indic
individu
protect
equip
must
chosen
accord
agent
activ
perform
user
consid
complianc
user
adequaci
fit
effect
seal
wear
wellfit
protect
equip
long
period
time
could
impair
satisfactori
perform
duti
health
care
provid
henc
adequ
costeffect
strategi
still
need
vaccin
main
strategi
control
outbreak
number
infecti
diseas
includ
flu
pandem
state
advanc
control
measur
definit
requir
sinc
vaccin
take
time
becom
avail
tuberculosi
tb
caus
mycobacterium
tuberculosi
curabl
transmiss
maladi
known
least
year
organ
estim
two
billion
peopl
around
world
infect
tuberculosi
eight
million
new
activ
case
tb
report
annual
mostli
ageproduct
adult
two
million
peopl
die
tb
previou
year
histori
becom
lead
killer
adult
worldwid
tuberculosi
develop
resist
multipl
firstlin
antitb
drug
mdrtb
type
resist
spiral
cost
beyond
time
per
patient
bring
suffer
countri
afflict
tb
involuntari
quarantin
tb
patient
nonadher
attitud
enforc
last
resourc
measur
control
spread
cystic
fibrosi
recurr
persist
respiratori
infect
pseudomona
aeruginosa
major
caus
morbid
mortal
cf
patient
jone
et
al
conclud
crossinfect
outbreak
p
aeruginosa
caus
respiratori
aerosol
dissemin
infecti
respiratori
diseas
whether
viral
bacteri
transmit
noninfect
subject
infect
patient
expel
pathogen
microorgan
surround
environ
cough
sneez
even
possibl
talk
duguid
determin
number
particl
less
diamet
contain
aerosol
form
speak
particl
cough
particl
sneez
particl
fennelli
studi
size
infecti
particl
gener
cough
estim
close
fine
particl
less
rang
small
enough
reach
alveoli
within
lung
transmiss
respiratori
pathogen
least
three
compon
requir
transmissor
sourc
infect
person
b
surround
environ
c
recipi
noninfect
person
import
addit
consid
concentr
infecti
particl
determin
volum
space
ventil
length
time
exposur
well
statu
defens
mechan
expos
individu
prompt
research
question
possibl
control
transmiss
infecti
respiratori
diseas
modul
physic
characterist
viscoelast
cohes
surfac
tension
respiratori
secret
minim
aerosol
facilit
transmiss
airborn
diseas
transmissionblock
approach
found
literatur
search
report
regard
type
approach
drug
test
mucomodul
establish
fundament
criterion
modul
physic
characterist
respiratori
secret
reduc
aerosol
without
affect
normal
clearanc
function
even
better
improv
henc
focus
attent
mucu
layer
airway
mucin
macromolecul
figur
consist
protein
core
surround
short
oligosaccharid
sidechain
held
togeth
differ
link
oglycosid
bond
disulphid
bridg
hydrogen
bond
ionic
bond
target
exist
mucolyt
agent
mucu
along
serou
fluid
form
airway
surfac
fluid
asf
provid
protect
milieu
airway
composit
physic
characterist
asf
allow
normal
ciliari
activ
airway
protect
disrupt
normal
secretori
mucociliari
clearanc
process
occur
respiratori
secret
accumul
impair
pulmonari
function
reduc
lung
defens
increas
risk
infect
possibl
neoplasia
ninetyf
per
cent
mucu
water
remain
made
protein
carbohydr
salt
etc
therefor
airway
mucu
layer
interact
highspe
airflow
cough
format
droplet
differ
size
expel
surround
environ
aerosol
concentr
droplet
size
distribut
may
play
import
role
transmiss
respiratori
infecti
diseas
microns
droplet
dri
quickli
remain
airborn
long
period
reach
lower
respiratori
system
schemat
diagram
macromolecul
mucu
differ
type
crosslink
figur
schemat
diagram
macromolecul
mucu
differ
type
crosslink
sodium
tetrabor
would
contribut
crosslink
format
involv
access
galactos
moieti
oligosaccharid
sidechain
calcium
chlorid
would
add
crosslink
dival
ionic
interact
mucin
macromolecul
posit
neg
fix
charg
capabl
interact
hbond
link
oligosaccharid
sidechain
interdigit
oligosaccharid
moieti
may
import
inhal
breathabl
particl
might
indirectli
infect
mani
person
eg
via
common
ventil
system
contrast
larg
droplet
propel
onto
nearest
surfac
oral
respiratori
ocular
mucosa
nearbi
person
settl
readili
floor
regard
transmiss
larger
particl
may
immedi
effect
direct
limit
microns
particl
may
indirect
effect
longerlast
widespread
consequ
studi
basic
goal
assess
new
gener
mucomodul
novel
approach
potenti
modul
physic
characterist
mucin
glycoprotein
gel
network
intervent
would
increas
mucin
crosslink
bind
site
reduc
aerosoliz
mucu
simul
surrog
transmiss
andor
form
poorli
solubl
mucin
complex
aim
achiev
former
interf
minim
normal
mucu
clearanc
hope
even
improv
clearabl
patient
airway
mucu
retent
hypothesi
transmiss
airborn
diseas
control
implement
coadjuv
pharmacolog
intervent
addit
indic
standard
treatment
aim
modul
physic
biochem
characterist
respiratori
secret
transmissor
carri
infect
minim
expector
materi
carri
pathogen
noninfect
potenti
recipi
phase
use
mucu
simul
test
effect
mucomodul
also
use
ex
vivo
frog
palat
exposur
model
combin
simul
cough
machin
assess
clearabl
well
aerosol
format
capabl
artifici
mucu
without
mucomodul
ms
rang
nonvisc
nonelast
substanc
water
ms
vari
degre
viscos
elast
prepar
viscoelast
mucu
simul
follow
procedur
describ
king
et
al
mucu
simul
formul
develop
transport
within
normal
rang
veloc
ciliat
epithelium
clear
simul
cough
machin
scm
set
close
normal
human
cough
mucu
simul
viscousonli
prepar
dissolv
differ
concentr
locust
bean
gum
lbg
warm
ringer
solut
ad
activ
charcoal
bromophenol
blue
coomassi
blue
dye
solut
better
visual
bullfrog
rana
catesbiana
upper
portion
head
remov
follow
procedur
describ
previou
work
cut
scissor
junction
posterior
pharynx
esophagu
skin
back
procedur
carri
lower
bodi
temperatur
frog
minut
insid
refriger
abolish
pain
sensat
palat
examin
macroscop
lesion
ulcer
petechia
red
evid
inflamm
palat
free
inflammatori
indic
use
blood
remain
epitheli
surfac
care
wash
away
excis
head
place
palat
side
face
upward
piec
gauz
satur
frog
ringer
solut
fr
petri
dish
palat
place
insid
frog
chamber
wooden
box
glass
top
fit
glass
front
manipul
glove
open
humid
insid
box
maintain
near
use
pari
jet
nebul
temperatur
kept
rheostatcontrol
extern
mount
light
sourc
carri
measur
palat
allow
stabil
insid
box
minut
test
fr
prepar
mix
standard
ringer
inject
steril
water
composit
standard
frog
ringer
mmoll
nacl
kcl
mosml
health
scienc
anim
polici
welfar
committe
univers
alberta
approv
experiment
procedur
involv
anim
palat
place
dissect
stereomicroscop
provid
reticul
eyepiec
mucociliari
clearanc
determin
observ
movement
particl
charcoal
powder
gentli
deposit
sampl
simul
mucu
palat
surfac
clearanc
visual
monitor
mtv
determin
displac
endogen
frog
mucu
sampl
calcul
divid
distanc
travel
transit
time
across
mm
segment
mark
inch
graduat
eyepiec
obtain
control
simul
mucu
transport
veloc
least
five
measur
time
requir
mucu
sampl
travel
defin
distanc
made
sampl
tissu
mucu
frog
palat
expos
topic
applic
mucomodul
immers
glutaraldehyd
store
later
scan
electron
microscop
sem
studi
epitheli
tissu
care
dissect
separ
palat
musculatur
assess
aerosol
pattern
form
cough
use
rang
fluid
vari
physic
characterist
nonvisc
nonelast
substanc
water
highli
viscoelast
substanc
simul
mucu
sampl
vari
degre
viscos
elast
better
visual
dispers
pattern
fluid
expos
highspe
airflow
scm
stain
fluid
capac
fluid
form
thread
stretch
express
elast
assess
filancemet
sefam
franc
prior
exposur
airflow
scm
volum
approxim
sampl
studi
introduc
reservoir
suck
low
current
appli
sampl
voltag
suppli
sampl
stretch
vertic
apparatu
electron
measur
maximum
length
thread
moment
ruptur
thread
everi
mucu
sampl
four
measur
length
thread
moment
ruptur
made
use
comput
spinnabl
mm
simul
cough
machin
use
test
main
hypothesi
modul
mucu
result
less
aerosol
airborn
materi
follow
cough
sinc
cough
critic
process
mucu
aerosol
success
reduct
droplet
product
cough
like
predict
reduc
amount
emit
sneez
speak
fluid
place
differ
distanc
mouth
open
simul
airway
examin
distanc
target
may
factor
determin
dispers
pattern
later
decid
fix
distanc
place
sampl
ms
expos
highspe
airflow
interact
target
bullseyetyp
circl
within
circl
also
place
paper
sheet
later
side
top
target
sheet
account
fluid
dispers
area
target
sheet
modifi
simul
cough
machin
system
compris
follow
element
tank
compress
air
serv
pressur
reservoir
gener
airflow
simul
lung
cough
maneuv
pressur
gener
prior
normal
adult
cough
approxim
psi
use
pressur
valu
simul
airflow
pattern
human
cough
trial
modifi
machin
model
airway
trachea
consist
cm
long
rigid
acryl
tube
circular
cm
crosssect
cm
detach
muzzl
endpiec
g
enabl
us
weigh
sampl
ms
load
immedi
cough
maneuv
report
mass
ms
expel
retain
solenoid
valv
locat
pressur
reservoir
model
trachea
control
ga
releas
tank
aliquot
sputum
layer
bottom
model
trachea
driven
forward
pressur
ga
distanc
travel
sputum
sampl
standard
coughsimul
airflow
use
measur
cough
clearabl
target
place
work
distanc
cm
mouth
scm
simul
cough
maneuv
repeat
four
time
sputum
sampl
airway
clearanc
expector
mucu
simul
airway
measur
weight
ms
sampl
load
cough
maneuv
carri
mettler
ae
microbal
sampl
mucu
tissu
place
glutaraldehyd
solut
immedi
collect
store
process
sampl
postfix
osmium
tetroxid
millonig
buffer
room
temperatur
one
hour
wash
seri
ethanol
ten
minut
step
follow
two
addit
period
absolut
ethanol
minut
sampl
dehydr
critic
point
dri
minut
mount
specimen
holder
sem
dri
overnight
vacuum
desicc
final
stage
prepar
view
sampl
sputter
coat
gold
edward
model
sputter
coater
sampl
view
use
sem
hitachi
imag
scan
directli
comput
store
imag
file
subsequ
view
analysi
explor
four
differ
approach
potenti
accomplish
primari
goal
reduc
aerosol
mucu
promot
airway
clearanc
howev
purpos
studi
report
two
sodium
tetrabor
name
also
xl
b
mucomodul
b
calcium
chlorid
name
also
xl
c
mucomodul
c
approach
high
molecular
weight
dextran
name
also
xl
mucomodul
polyarginin
name
also
xl
mucomodul
report
independ
public
sodium
tetrabor
caus
revers
crosslink
format
galactos
unit
major
neutral
sugar
compon
mucin
addit
borat
galactos
polym
preferenti
rais
elast
rel
viscos
ad
three
differ
volum
borat
ms
produc
three
level
crosslink
expos
gel
four
cough
maneuv
measur
per
trial
calcium
chlorid
increas
concentr
dival
cation
mucu
conceptu
opposit
occur
natur
mucin
exocytosi
intracellular
mucin
granul
held
tightli
ion
crosslink
give
way
much
looser
interact
ion
exchang
occur
fusion
apic
membran
volum
frog
ringer
three
differ
concentr
calcium
chlorid
directli
appli
micropipett
fresh
frog
palat
order
assess
effect
mucu
transport
veloc
morpholog
tissu
mucu
layer
data
express
mean
standard
deviat
unless
otherwis
state
pair
studentt
test
use
simpl
comparison
neumankeul
analysi
appli
repeat
measur
level
signific
set
studi
report
effect
mucomodul
xl
b
ms
spinnabl
clearanc
ciliari
action
highveloc
airflow
interact
cough
maneuv
well
effect
xl
c
physic
appear
frog
mucu
nativ
mucu
transport
frog
palat
stain
sampl
bromophenol
blue
made
ms
solut
wateri
reduc
viscos
ms
henc
reject
use
dye
test
activ
charcoal
alter
viscoelast
properti
ms
sampl
help
better
visual
gel
sampl
frog
palat
howev
charcoal
add
mass
sampl
eventu
might
alter
dispers
pattern
coomassi
blue
alter
viscoelast
properti
ms
henc
use
dye
sampl
sampl
ms
nonvisc
nonelast
properti
frog
ringer
solut
approxim
ml
room
temperatur
place
frog
palat
dispers
surfac
transport
ciliari
action
viscousonli
sampl
low
rang
concentr
lbg
maintain
shape
dispers
epitheli
surfac
propel
ciliari
action
viscousonli
sampl
higher
concentr
rang
lbg
maintain
shape
transport
slowli
ciliari
action
approxim
five
time
slower
control
nonvisc
nonelast
sampl
viscousonli
sampl
produc
measur
spinnabl
filancemet
work
sampl
viscoelast
ms
attain
repeat
length
filament
low
rang
mm
high
rang
mm
valu
filancemet
found
difficult
consist
obtain
medium
rang
mm
even
use
differ
combin
viscos
elast
ms
elast
crosslink
ms
length
filament
increas
direct
proport
volum
ad
borat
figur
pair
ttest
show
signific
differ
thread
format
compar
three
ad
volum
newmankeul
test
also
indic
signific
differ
p
thread
format
ms
compar
medium
ad
volum
high
volum
sodium
tetrabor
also
newmankeul
test
indic
signific
differ
p
thread
format
compar
low
ad
volum
high
volum
borat
averag
linear
veloc
transport
rate
ciliari
action
crosslink
mucu
simul
frog
palat
approxim
percent
effect
nativ
mucu
transport
use
control
differ
volum
sodium
tetrabor
appli
differ
volum
lower
concentr
borat
appli
transport
veloc
rate
percent
effect
control
cough
clearanc
nonvisc
nonelast
ms
sampl
water
place
variou
distanc
mouth
artifici
airway
expos
simul
cough
maneuv
high
degre
dispers
onto
bullsey
target
sampl
approxim
ml
crosslink
ms
stain
coomassi
blue
load
insid
detach
portion
artifici
airway
weigh
microbal
cough
machin
trigger
detach
portion
remain
aliquot
sampl
expel
cough
maneuv
immedi
weigh
amount
ms
expel
artifici
airway
increas
direct
proport
volum
sodium
tetrabor
ad
figur
pair
ttest
analysi
show
exist
signific
differ
compar
volum
ms
sampl
expel
increas
volum
ad
borat
newmankeul
test
indic
signific
differ
p
weight
ms
expel
scm
compar
low
ad
volum
xl
b
high
volum
xl
b
ms
load
simul
airway
expos
highspe
airflow
interact
simul
cough
broke
multipl
droplet
variou
size
expel
form
cloud
aerosol
land
target
portion
ms
expel
reach
target
land
piec
paper
place
along
later
side
corridor
mouth
target
amount
aerosol
strike
target
amount
fine
aerosol
decreas
progress
ad
volum
crosslink
agent
figur
volum
xl
b
ad
ms
sampl
invers
relat
number
droplet
form
cough
maneuv
airflow
interact
larger
volum
ad
fewer
droplet
form
also
observ
ad
volum
xl
b
borat
increas
size
droplet
form
airflow
interact
increas
henc
big
cohes
droplet
form
reach
target
fall
paper
place
immedi
exit
proport
ms
sampl
remain
airway
cough
maneuv
correspondingli
decreas
increas
effect
crosslink
agent
xl
b
sodium
tetrabor
spinnabl
artifici
mucu
figur
effect
crosslink
agent
xl
b
sodium
tetrabor
spinnabl
artifici
mucu
p
respect
p
respect
volum
xl
b
ad
volum
crosslink
agent
ad
sodium
tetrabor
xl
c
calcium
chlorid
appli
topic
ex
vivo
frog
palat
model
caus
mucu
clump
without
modifi
normal
physic
appear
ciliat
surfac
compar
ciliat
surfac
expos
frog
ringer
solut
figur
direct
applic
three
concentr
frog
palat
seem
moder
slow
way
nativ
frog
mucu
transport
ciliari
action
epitheli
model
figur
newmankeul
analog
procedur
show
signific
differ
p
mtv
frog
mucu
sampl
lowest
concentr
appli
compar
concentr
frog
ringer
control
studi
acquir
preliminari
evid
use
mucomodul
yield
accept
mucociliari
clearanc
ex
vivo
epitheli
model
increas
expector
model
system
yet
achiev
desir
target
signific
reduct
fine
aerosol
format
also
obtain
graphic
evid
one
mucomodul
agent
calcium
chlorid
increas
concentr
dival
cation
fact
increas
interact
ion
crosslink
frog
mucu
result
modif
physic
structur
cough
clearanc
expector
sodium
tetrabor
xl
b
crosslink
mucou
gel
simul
ie
percentag
initi
load
clear
mouth
artifici
trachea
cough
maneuv
enhanc
valid
obtain
result
formul
artifici
mucu
accord
king
display
physic
properti
viscos
elast
reproduc
thread
format
transport
ciliat
epithelium
within
accept
rang
close
simul
airway
mucu
aerosoliz
ms
modifi
increas
cohes
therebi
reduc
number
particl
expel
scm
interf
minim
clearanc
frog
palat
unexpect
find
ms
crosslink
increas
expector
rubin
van
der
schan
state
intervent
thought
directli
measur
effect
sputum
properti
sputum
clearabl
chang
demonstr
vitro
unlik
observ
clinic
trial
result
present
articl
obtain
thu
far
model
system
mucou
gel
simul
artifici
airway
simul
cough
function
ex
vivo
epitheli
modelar
limit
strike
clearli
support
mucomodul
approach
encourag
continu
vivo
mammalian
model
present
independ
expect
similar
result
eventu
observ
clinic
trial
result
studi
suggest
mucomodul
test
appear
affect
morpholog
function
mucociliari
apparatu
design
new
mucomodul
therapi
aim
chang
physic
properti
asf
enhanc
clearanc
mucu
respiratori
tract
well
optim
aspect
lung
defens
depend
mucou
layer
mucomodul
work
differ
mucolyt
sinc
latter
design
disrupt
structur
macromolecul
give
respiratori
tract
mucu
physic
characterist
agent
design
increas
mucu
flow
stimul
ciliari
activ
improv
periciliari
fluid
hydrat
use
mucomodul
act
increas
cohes
airway
mucu
simul
mucomodul
therapi
combat
mucu
retent
may
becom
major
consider
treatment
cystic
fibrosi
chronic
lung
diseas
mucu
hypersecret
impair
airway
clearanc
produc
symptom
requir
adequ
novel
secret
manag
mucomodul
approach
intend
adjust
regul
mucin
macromolecul
give
respiratori
mucu
physic
characterist
order
minim
aerosol
facilit
transmiss
airborn
diseas
note
normal
aerosol
dispers
pattern
effect
sodium
tetrabor
crosslink
mucou
gel
simul
figur
aerosol
dispers
pattern
effect
sodium
tetrabor
crosslink
mucou
gel
simul
aerosol
pattern
cm
follow
standard
cough
maneuv
amount
aerosol
strike
target
amount
fine
aerosol
decreas
progress
ad
crosslink
agent
cough
aerosol
particl
breath
other
although
common
thu
potenti
therapi
could
reduc
tendenc
aerosol
particl
cough
consid
form
modul
sens
restor
balanc
state
homeostasi
cellular
debri
byproduct
infect
contribut
make
difficult
clearanc
infect
mucu
cf
patient
requir
antibiot
mucolyt
therapi
approach
help
reduc
mortal
rate
cf
patient
howev
still
remain
long
way
go
reduc
transmiss
pathogen
noninfect
subject
invent
novel
nonintuit
approach
improv
airway
mucu
clearanc
ad
crosslink
select
control
manner
special
new
gener
mucomodul
test
bear
initi
find
could
lead
treatment
would
reduc
rate
morbid
improv
qualiti
life
individu
difficulti
airway
secret
manag
essenti
found
preliminari
evid
certain
mucomodul
increas
cohes
interact
mucin
macromolecul
lead
mucu
easili
clearabl
like
airflowdepend
mechan
suggest
result
obtain
effect
crosslink
agent
calcium
chlorid
xl
c
physic
chang
fresh
frog
mucu
figur
effect
crosslink
agent
calcium
chlorid
xl
c
physic
chang
fresh
frog
mucu
se
micrograph
show
clump
effect
calcium
chlorid
appli
topic
frog
palat
ciliat
surfac
palat
seen
mucu
appear
differ
control
view
scm
latter
preliminari
answer
recur
question
lung
expert
use
approach
could
gum
airway
secret
improv
mucu
qualiti
relat
clearanc
would
benefit
mani
patient
chronic
airway
diseas
includ
suffer
chronic
obstruct
pulmonari
diseas
depend
whole
part
airflow
clearanc
mechan
maintain
airway
hygien
work
need
clarifi
mechan
involv
clearanc
airway
secret
novel
approach
might
particular
import
icu
spinal
cord
lesion
requir
assist
ventil
time
increas
cohes
manner
lead
reduct
fine
aerosol
format
expector
clear
advantag
help
control
spread
airborn
infect
new
approach
may
applic
rang
infecti
diseas
threat
occur
natur
like
fear
next
flu
pandem
possibl
deliber
use
biolog
agent
addit
critic
advantag
novel
technolog
health
canada
us
fda
regulatori
agenc
alreadi
approv
select
compound
pharmaceut
use
human
compound
combin
thereof
judg
suitabl
clinic
trial
establish
safeti
data
could
util
fulfil
regulatori
requir
preclin
studi
area
applic
would
includ
transmiss
prevent
clinic
epidemiolog
import
pathogen
like
tuberculosi
mdrtb
fear
flu
pandem
sarscov
well
p
aeruginosa
cystic
fibrosi
mucomodul
would
like
repres
contain
transmiss
respiratori
pathogen
especi
outbreak
allow
strateg
sector
societi
protect
remain
function
like
health
system
law
enforc
servic
provid
well
work
forc
critic
advantag
novel
technolog
low
cost
mucomodul
need
veloc
mmsec
undergo
constant
develop
reformul
due
viral
bacteria
mutat
resist
technolog
design
act
host
rather
caus
organ
provid
longev
compound
consider
less
perish
vaccin
amen
distribut
particularli
warm
climat
simpl
manufactur
even
allow
rapid
respons
outbreak
situat
addit
concept
test
could
involv
veterinari
trial
airborn
anim
diseas
aspect
also
explor
model
studi
use
veget
polysaccharid
sodium
tetrabor
preferenti
rais
elast
rel
viscos
current
knowledg
prior
develop
mucomodul
indic
tetrabor
solut
would
favour
mucociliari
clearabl
expens
cough
clearabl
aerosoliz
appear
cough
clearabl
aerosoliz
link
cohes
opposit
sens
least
within
rang
current
studi
thu
appear
sodium
tetrabor
solut
alter
mucou
gel
cohes
decreas
aerosoliz
fine
aerosol
format
cough
increas
cough
clearabl
bulk
clearanc
mucu
summari
mucomodul
technolog
innov
repres
revers
current
think
respiratori
diseas
manag
result
product
unpreced
type
tool
airway
hygien
secret
manag
well
prevent
dropletspread
ill
close
persontopersoncontact
airborn
transmiss
safe
efficaci
nonvaccin
prevent
therapi
author
declar
compet
interest
